A carregar...
A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma
Glioblastoma is the most malignant tumor and has high mortality rate. The methylated prompter of MGMT results in chemotherapy sensitivity for these patients. However, there are still other factors that affected the prognosis for the glioblastoma patients with similar MGMT methylation status. We deve...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342529/ https://ncbi.nlm.nih.gov/pubmed/27588397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11726 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|